AONC (American Oncology Network) Shares Outstanding (EOP): 27 Mil (As of Dec. 2024)


AONC American Oncology Network Inc AONC
20 GF Score
Price $10.00
View Full Analysis

What is American Oncology Network Shares Outstanding (EOP)?

American Oncology Network AONC 20 Shares Outstanding (EOP) is 27 Mil as of Dec. 2024. GuruFocus rates AONC with a GF Score™ of 20/100.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. American Oncology Network's shares outstanding for the quarter that ended in Dec. 2024 was 27 Mil.

American Oncology Network's quarterly shares outstanding increased from Sep. 2024 (13 Mil) to Dec. 2024 (27 Mil). It means American Oncology Network issued new shares from Sep. 2024 to Dec. 2024 .

American Oncology Network's annual shares outstanding increased from Dec. 2023 (10 Mil) to Dec. 2024 (27 Mil). It means American Oncology Network issued new shares from Dec. 2023 to Dec. 2024 .


American Oncology Network  (OTCPK:AONC) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


American Oncology Network Shares Outstanding (EOP) Related Terms


American Oncology Network Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for American Oncology Network's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Oncology Network Shares Outstanding (EOP) Chart

American Oncology Network Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Shares Outstanding (EOP)
9.53 9.53 9.53 9.52 27.23

American Oncology Network Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 9.52 10.34 13.50 13.22 27.23

AONC vs TOI, AUNA, AGL: Shares Outstanding (EOP) Comparison

For the Medical Care Facilities subindustry, American Oncology Network's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


American Oncology Network Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, American Oncology Network's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where American Oncology Network's Shares Outstanding (EOP) falls into.


AONC
20GF Score
American Oncology Network Inc AONC
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

American Oncology Network Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 27 Mil mean?
American Oncology Network (AONC) has a Shares Outstanding (EOP) of 27 Mil as of Dec. 2024. The total shares a company has outstanding, at period-end. View historical data on American Oncology Network and its competitors.
Is American Oncology Network's Shares Outstanding (EOP) too high?
American Oncology Network's current Shares Outstanding (EOP) is 27 Mil. Overall, American Oncology Network has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does American Oncology Network's Shares Outstanding (EOP) compare to TOI and AUNA?
American Oncology Network's Shares Outstanding (EOP) of 27 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on American Oncology Network and its competitors. American Oncology Network's current Shares Outstanding (EOP) is 27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Oncology Network stock overvalued right now?
American Oncology Network (AONC) has a current Shares Outstanding (EOP) of 27 Mil. The current Shares Outstanding (EOP) is 27 Mil. American Oncology Network's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For American Oncology Network (AONC), the current Shares Outstanding (EOP) is 27 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Oncology Network Business Description

Address 14543 Global Parkway, Suite 110, Fort Myers, FL, USA, 33913
American Oncology Network Inc through its subsidiary companies and variable interest entities, is an alliance of physicians and seasoned healthcare leaders who provide comprehensive oncology services across 37 oncology practices located in twenty states. The Company also provides expertise in drug procurement and payor contracting, along with practice diversification through centralized laboratory and pathology services, as well as specialty pharmacy services, clinical research, radiation oncology, and imaging.
20GF Score

Get the complete analysis for AONC

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.00
Price